Abbott Laboratories Accused of Racketeering in Epilepsy Drug Marketing Suit

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!Abbott Laboratories (ABT:US) allegedly engaged in racketeering when it led an effort to market the epilep…
Read the full story: BioSpace.com Featured News